European Companies Search Engine
Wordmark: “KYSO antibodies“ Euipotm 29 Sept 2022 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Word |
| Name | KYSO antibodies |
| Filing number | 018707297 |
| Trade mark status | REGISTERED |
| Nice Classification |
1: Chemical, biochemical, biological, and biotechnological preparations, especially antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals. 5: Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases. 42: Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these. 45: Patent exploitation and licensing of intellectual property in the field of medicine. |
| Filing date | 24/05/2022 |
| Registration date | 28/09/2022 |
| Expiry date | 24/05/2032 |
| Owners |
DK-1560 København V Denmark |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Genmab A/S, Valby, Denmark.
